Andrew Muntean, Ph.D.
Dr. Andrew Muntean received his B.S. in Biology from Indiana University (Bloomington, IN) in 1999. He earned his Ph.D. in Molecular Genetics and Cell biology from the University of Chicago (Chicago, IL) in 2006 studying transcriptional mechanisms governing hematopoiesis with Dr. John Crispino. Dr. Muntean completed postdoctoral training studying epigenetic and transcriptional mechanisms in leukemia with Dr. Jay Hess at the University of Michigan (Ann Arbor, MI).
Dr. Muntean has received several awards including a Fellow Scholar Award in Basic Science from the American Society of Hematology and a Howard Temin Pathway to Independence Award in Cancer Research from the National Cancer Institute/National Institute of Health. He is also a scholar of the American Cancer Society. Dr. Muntean has served as a reviewer of several scientific journals and is a member of the American Society of Hematology and the American Association of Cancer Research.
In July of 2012, Dr. Muntean joined the faculty in the Department of Pathology at the University of Michigan as an Assistant Professor.
Epigenetic and transcriptional mechanisms controlling normal and malignant hematopoietic stem cells